Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
Cancers|March 14, 2026
From Feasibility to Individualization: Surgery for Breast Cancer Liver and Lung MetastasesMartina Greco, Calogero Cipolla, Chiara Mesi, et al.Anti-Cancer Drugs|June 5, 2003
Escalating doses of paclitaxel and epirubicin in combination with cisplatin in advanced ovarian epithelial carcinoma: a phase I-II studyVittorio Gebbia, Pietro Di Marco, Nicolò Borsellino, et al.Anticancer Research|December 8, 2020
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real WorldVittorio Gebbia, Andrea Girlando, Alfio DI Grazia, et al.Oncology Research and Treatment|December 12, 2022
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic ReviewAntonio Piras, Antonella Sanfratello, Luca Boldrini, et al.Tumori|October 14, 2006
Clinical presentation and treatment of gastrointestinal stromal tumorsCalogero Cipolla, Fabio Fulfaro, Luigi Sandonato, et al.In Vivo (Athens, Greece)|April 28, 2026
Observational Study on the Effectiveness of L-Arginine Plus Vitamin C in the Management of Cancer-related FatigueVittorio Gebbia, Giuseppa Scandurra, Daniela Sambataro, et al.Cancers|April 14, 2025
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic StrategyDaniela Sambataro, Sandro Bellavia, Paolo Di Mattia, et al.Urologic Oncology|October 12, 2019
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?Vincenzo Serretta, Maria Rosaria Valerio, Renato Costa, et al.Current Oncology (Toronto, Ont.)|May 24, 2024
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi ApproachDario Piazza, Federica Martorana, Annabella Curaba, et al.Anticancer Research|May 4, 2005
Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancerPatrizia Vici, Paolo Foggi, Giuseppe Colucci, et al.Pageof 10